TrialEBioMedicine2025

An open-label study on the safety and immunogenicity of a PD-1-enhanced DNA vaccine used as a T cell booster for COVID-19.

Yik Chun Wong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.